|
US2012289486A1
|
|
Treatment of eyelid dermatitis
|
|
US2008194468A1
|
|
Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
|
|
US2008004246A1
|
|
Transporter enhanced corticosteroid activity
|
|
EP1957451A1
|
|
Soft anticholinergic zwitterions
|
|
EP1948596A2
|
|
Soft anticholinergic esters
|
|
WO2004112800A1
|
|
Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
|
|
MXPA05013898A
|
|
Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application.
|
|
US6610675B1
|
|
Inactive metabolite approach to soft drug design
|
|
US5334601A
|
|
Soft β-adrenergic blocking agents
|
|
US5202347A
|
|
Soft β-adrenergic blocking agents
|
|
US5135926A
|
|
Soft β-adrenergic blocking agents
|
|
US5082853A
|
|
Brain-specific analogues of centrally acting amines
|
|
WO8903390A1
|
|
Soft steroids having anti-inflammatory activity
|
|
US4829086A
|
|
Soft β-adrenergic blocking agents
|
|
US4703042A
|
|
Orally active heparin salts containing multivalent cationic units
|
|
US4996335A
|
|
Soft steroids having anti-inflammatory activity
|
|
EP0189427A1
|
|
Orally active heparin multiplets.
|
|
EP0174956A1
|
|
SOFT -g(b)-ADRENERGIC BLOCKING AGENTS.
|
